CR

CreoSG Co.,Ltd.

Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.

040350 | KO

Overview

Corporate Details

ISIN(s):
KR7040350001
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로13길 31-1 4층(역삼동, 일리빌딩), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CreoSG Co., Ltd. operates as a diversified company with two primary business segments: IT solutions and biotechnology. The IT division specializes in developing and supplying software and next-generation systems for financial institutions, offering services that include application development, IT outsourcing, and infrastructure management. Concurrently, the company has a significant focus on the biotechnology sector, primarily conducting vaccine research and development. This division leverages a proprietary recombinant VSV (Vesicular Stomatitis Virus) vector platform technology to develop novel vaccines, with key projects targeting HIV/AIDS and various coronaviruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정-소액공모)
Korean 7.5 KB
2025-09-19 00:00
Share Issue/Capital Change
소액공모실적보고서
Korean 29.0 KB
2025-09-18 00:00
Major Shareholding Notification
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Korean 19.8 KB
2025-09-11 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 51.0 KB
2025-09-11 00:00
Share Issue/Capital Change
소액공모공시서류(지분증권)
Korean 2.2 MB
2025-09-10 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 60.5 KB
2025-09-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 163.4 KB
2025-09-03 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 39.7 KB
2025-09-01 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제22회차)
Korean 9.3 KB
2025-08-29 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 44.9 KB
2025-08-20 00:00
Regulatory News Service
불성실공시법인지정 (공시불이행)
Korean 6.1 KB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.9 MB
2025-07-30 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 44.6 KB
2025-07-29 00:00
Regulatory News Service
불성실공시법인지정예고 (공시불이행)
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all CreoSG Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CreoSG Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CreoSG Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Moolec Science SA Logo
Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.
United States of America
MLEC
MoonLake Immunotherapeutics Logo
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
United States of America
MLTX
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland
MURA
N2OFF, Inc. Logo
Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.
United States of America
NITO
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan
4571
NATIONAL RESEARCH CORP Logo
AI-powered platform with analytics to measure and improve the healthcare experience for everyone.
United States of America
NRC
NATURAL RESOURCE PARTNERS LP Logo
Manages and leases a diverse portfolio of mineral and energy properties for royalty income.
United States of America
NRP
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea
007390
Nautilus Biotechnology, Inc. Logo
Developing a proteomics platform for single-molecule analysis to advance life sciences research.
United States of America
NAUT
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan
4196

Talk to a Data Expert

Have a question? We'll get back to you promptly.